Home Cart Sign in  
Chemical Structure| 1257423-87-2 Chemical Structure| 1257423-87-2

Structure of BTdCPU
CAS No.: 1257423-87-2

Chemical Structure| 1257423-87-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BTdCPU is acts as an inhibitor of the formation of the ternary complex of eukaryotic translation initiation factor 2 (eIF2), GTP and the initiator methionine tRNA (Met-tRNAi), a key regulatory step of translation initiation.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BTdCPU

CAS No. :1257423-87-2
Formula : C13H8Cl2N4OS
M.W : 339.20
SMILES Code : O=C(NC1=CC=C(Cl)C(Cl)=C1)NC2=CC=C3N=NSC3=C2
MDL No. :MFCD32004476
InChI Key :NUUSUAWULNXMGF-UHFFFAOYSA-N
Pubchem ID :49787174

Safety of BTdCPU

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of BTdCPU

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary MM patient cells 10 μM 24 h Exhibited significant cytotoxicity towards dex-resistant MM patient cells Leuk Res. 2017 Apr;55:23-32
U266 cells 10 μM 48 h Promoted cell death Leuk Res. 2017 Apr;55:23-32
RPMI8266 cells 10 μM 48 h Promoted cell death Leuk Res. 2017 Apr;55:23-32
H929 cells 10 μM 48 h Promoted cell death Leuk Res. 2017 Apr;55:23-32
MM1.R cells 10 μM 4-8 h Induced phosphorylation of eIF2α and upregulation of CHOP expression, promoting apoptosis Leuk Res. 2017 Apr;55:23-32
MM1.S cells 10 μM 4-8 h Induced phosphorylation of eIF2α and upregulation of CHOP expression, promoting apoptosis Leuk Res. 2017 Apr;55:23-32
PAX5-JAK2 Ba/F3 cells 5 μM 9 h BTdCPU induced MCL-1 repression via HRI-dependent pathway and triggered the integrated stress response downstream targets CHOP and ATF4. Mol Cancer Res. 2021 Apr;19(4):636-650
Human Ph+ BV-173 cells 5 μM 24 h BTdCPU induced MCL-1 repression via HRI-dependent pathway and triggered the integrated stress response downstream targets CHOP and ATF4. Mol Cancer Res. 2021 Apr;19(4):636-650
Mouse BCR-ABL+ B-ALL cells 5 μM 16 h BTdCPU induced MCL-1 repression via HRI-dependent pathway and triggered the integrated stress response downstream targets CHOP and ATF4. Mol Cancer Res. 2021 Apr;19(4):636-650
Perk+/+ and Perk−/− MEFs 10 μM 3 h Increased ATF4 expression, restoring ISR signaling in Perk−/− MEFs Cell Chem Biol. 2023 Dec 21;30(12):1571-1584. e5
HEK293T cells 10 μM 8 h Activated ATF4-FLuc ISR reporter, demonstrating ISR activation through HRI Cell Chem Biol. 2023 Dec 21;30(12):1571-1584. e5

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice BCR-ABL+ B-ALL leukemia model Intraperitoneal injection 400 mg/kg/day Daily administration for 14 days Combination therapy of BTdCPU with BH3-mimetic ABT-263 significantly extended survival of leukemia-bearing mice and repressed MCL-1 expression in vivo. Mol Cancer Res. 2021 Apr;19(4):636-650

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.95mL

0.59mL

0.29mL

14.74mL

2.95mL

1.47mL

29.48mL

5.90mL

2.95mL

References

 

Historical Records

Categories